The short answer
The literature reports effects on extracellular matrix biosynthesis, antioxidant activity through copper delivery to superoxide dismutase, wound-repair models and broad gene-expression modulation. It is predominantly in vitro and animal work, with a notable concentration of authorship.
Key facts
- Main reported areas
- Matrix biosynthesis, antioxidant, gene expression
- Evidence type
- Predominantly in vitro and animal
- Mechanism established
- Copper binding: not in doubt
- Mechanism proposed
- Copper delivery to cuproenzymes
- Receptor
- None characterised
- Authorship
- Concentrated in one long programme
What is solidly established
That GHK binds copper(II) with high affinity through a defined ATCUN-type site, forming a discrete complex with its own CAS registration and characteristic blue colour. This is straightforward coordination chemistry, independently verifiable, and nothing in the literature disputes it.
What is well supported
That the complex affects matrix biosynthesis in cell culture, and that copper delivery to lysyl oxidase and superoxide dismutase is a coherent mechanism for a meaningful portion of that. The chemistry and the enzyme dependencies are independently known, which makes this more than an isolated observation.
Research material referenced
GHK-Cu 100mg, third-party HPLC tested
What is reported but weakly grounded
Broad gene-expression modulation, real as a measurement, but from Connectivity Map analysis of cultured cell lines, and several steps upstream of function. Interactions with growth-factor signalling, which lack a defined mechanism. And the anti-ageing framing, which rests on an age-decline correlation rather than on intervention evidence.
What is absent
A characterised receptor. Substantial human clinical data. Independent replication of the broader claims by unconnected groups. None of these absences refutes anything; together they define how far the evidence currently reaches.
How the evidence compares
GHK-Cu is better grounded than DSIP, which has no gene, no receptor and an unresolved central claim. It is less well grounded than the incretins, which have large randomised trials with hard endpoints. It sits where most research peptides sit: real chemistry, plausible mechanism, model-system evidence, and a gap before anything can be said about people.
How to search it
PubMed indexes the field under GHK-Cu and under glycyl-histidyl-lysine; prezatide and copper tripeptide-1 surface further records. Checking the model system and the author list on any given paper is the fastest way to establish what kind of evidence it offers and how independent it is.
Frequently asked questions
What is definitely true about GHK-Cu?
That it binds copper(II) with high affinity through a defined site, forming a discrete blue complex. That chemistry is not in dispute.
Is there human clinical evidence?
Limited. The literature is predominantly in vitro and animal work.
How does the evidence compare to other research peptides?
Better grounded than DSIP, which has no receptor and an unresolved central claim; far less than the incretins with their large randomised trials.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedPickart L & Margolina A. Biomed Res Int 2015 (PMID 26236730)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L, GHK-Cu in prevention of oxidative stress. Oxid Med Cell Longev 2012 (PMID 22666519)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L et al., Effect of GHK on gene expression. Brain Sci 2017 (PMID 28212278)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L, The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 2008 (PMID 18644225)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Glycyl-L-histidyl-L-lysine (CID 73587)pubchem.ncbi.nlm.nih.gov
- PubChemPubChem · GHK-Cu copper complex (CID 71587328)pubchem.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More GHK-Cu (Copper Peptide) articles
- What Is Actually In a Copper Peptide Serum?Copper tripeptide-1 is the cosmetic name for GHK-Cu, and cosmetics carry a fraction of a percent of it. What the label means, and how formulations differ.
- Does Topical GHK-Cu Absorb Through Skin?At 340 daltons free and 404 as the copper complex, GHK-Cu is small enough to cross the stratum corneum - unusual for a peptide, and the strongest case for it.
- GHK-Cu Benefits, and How Well Evidenced They AreCollagen, wound repair, antioxidant and gene-expression claims - separated by how strong the evidence behind each actually is, and who produced it.
- GHK-Cu Side EffectsNo controlled safety dataset exists. What is reported comes from cosmetic use and is mostly irritation, plus the copper questions that rarely get answered.
- Copper Peptides and HairThe hair claim is weaker than the skin claim and rests on different studies. What has been shown about follicles, and why AHK-Cu is usually sold for hair.